Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M104,256Revenue $M7,670Net Margin (%)26.1Altman Z-Score6.9
Enterprise Value $M104,383EPS $2.4Operating Margin %31.7Piotroski F-Score7
P/E(ttm)50.0Beneish M-Score-2.6Pre-tax Margin (%)30.7Higher ROA y-yY
Price/Book16.510-y EBITDA Growth Rate %--Quick Ratio3.2Cash flow > EarningsY
Price/Sales13.05-y EBITDA Growth Rate %23.1Current Ratio3.3Lower Leverage y-yY
Price/Free Cash Flow41.2y-y EBITDA Growth Rate %45.8ROA % (ttm)13.0Higher Current Ratio y-yN
Dividend Yield %--PEG2.2ROE % (ttm)36.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M791ROIC % (ttm)38.2Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CELGKen Fisher 2015-06-30 Reduce$107.54 - $120.34
($114.34)
$ 131.6615%Reduce 2.40%224,399
CELGRonald Muhlenkamp 2015-03-31 Reduce-0.02%$110.51 - $128.5
($119.49)
$ 131.6610%Reduce 0.81%85,540
CELGJoel Greenblatt 2015-03-31 Add0.01%$110.51 - $128.5
($119.49)
$ 131.6610%Add 75.33%17,987
CELGMario Gabelli 2015-03-31 Reduce$110.51 - $128.5
($119.49)
$ 131.6610%Reduce 0.08%24,940
CELGKen Fisher 2015-03-31 Add$110.51 - $128.5
($119.49)
$ 131.6610%Add 1.14%229,918
CELGRonald Muhlenkamp 2014-12-31 Reduce-1.03%$86.38 - $118.68
($105.53)
$ 131.6625%Reduce 41.31%86,240
CELGJoel Greenblatt 2014-12-31 Buy 0.01%$86.38 - $118.68
($105.73)
$ 131.6625%New holding10,259
CELGGeorge Soros 2014-09-30 Sold Out -0.45%$83.13 - $96.21
($90.29)
$ 131.6646%Sold Out0
CELGJoel Greenblatt 2014-09-30 Sold Out -0.07%$83.13 - $96.21
($90.29)
$ 131.6646%Sold Out0
CELGKen Fisher 2014-09-30 Add0.02%$83.13 - $96.21
($90.29)
$ 131.6646%Add 77.12%232,137
CELGRonald Muhlenkamp 2014-06-30 Reduce-1.91%$68.45 - $86.8
($75.89)
$ 131.6673%Reduce 51.74%144,140
CELGGeorge Soros 2014-06-30 Buy 0.45%$68.45 - $86.8
($75.89)
$ 131.6673%New holding688,000
CELGJoel Greenblatt 2014-06-30 Buy 0.07%$68.45 - $86.8
($75.89)
$ 131.6673%New holding63,980
CELGKen Fisher 2014-06-30 Add0.01%$68.45 - $86.8
($75.89)
$ 131.6673%Add 75.59%131,064
CELGRonald Muhlenkamp 2014-03-31 Add0.05%$69.645 - $85.97
($79.19)
$ 131.6666%Add 1.29%298,650
CELGKen Fisher 2014-03-31 Add0.01%$69.645 - $85.97
($79.19)
$ 131.6666%Add 1591.80%74,642
CELGMario Gabelli 2014-03-31 Reduce$69.645 - $85.97
($79.19)
$ 131.6666%Reduce 3.58%21,540
CELGJohn Keeley 2014-03-31 Sold Out $69.65 - $85.97
($79.19)
$ 131.6666%Sold Out0
CELGRonald Muhlenkamp 2013-12-31 Add0.12%$72.245 - $85.385
($79.13)
$ 131.6666%Add 2.87%294,850
CELGKen Fisher 2013-12-31 Reduce$72.245 - $85.385
($79.13)
$ 131.6666%Reduce 11.41%4,412
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CELG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Daniel Thomas Osee remarks 2015-07-28Sell29,720$133.96-1.55view
Daniel Thomas Osee remarks 2015-07-13Sell30,156$120.789.19view
KAPLAN GILLADirector 2015-06-10Sell15,000$111.7418.02view
CASEY MICHAEL DDirector 2015-06-09Sell15,000$111.1818.62view
STEIN LAWRENCE VSee Remarks 2015-05-14Sell2,542$114.8514.83view
KAPLAN GILLADirector 2015-02-26Sell15,000$122.897.32view
CASEY MICHAEL DDirector 2015-02-25Sell15,000$123.197.05view
KARSEN PERRY Asee remarks 2015-02-11Sell27,896$120.129.79view
Alles Mark JSee Remarks 2015-02-06Sell117,099$120.689.28view
STEIN LAWRENCE VSee Remarks 2015-01-15Sell26,666$120.019.89view

Press Releases about CELG :

Quarterly/Annual Reports about CELG:

News about CELG:

Articles On GuruFocus.com
Stocks Jul 30 2015 
scottrade Jul 24 2015 
scottrade Jul 24 2015 
scottrade Jul 24 2015 
scottrade Jul 24 2015 
My Top 3 Pharma Stock Picks Jun 09 2015 
10 Reasons Why Growth Stocks Can Be Appropriate for Retired Investors Jun 04 2015 
Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
jee's porfolio May 23 2015 
Celgene’s Earnings Shine While Revenue Misses By An Inch In The First Quarter May 06 2015 

More From Other Websites
10-Q for Celgene Corp. Jul 30 2015
Celgene is pushed into paying a high price for Receptos Jul 30 2015
Large-Cap Healthcare Stocks Outperform Small Caps Jul 30 2015
Celgene Corp. Earnings Analysis: By the Numbers Jul 30 2015
Celgene says patent-fighting hedge fund manager wants to short its shares Jul 29 2015
Drugmakers Strike Back: Kyle Bass Blasted Over Patent Challenges Jul 29 2015
Q2 Earnings Season Halftime Report Jul 29 2015
Four Reasons Gilead Can Head Higher Jul 29 2015
Bristol-Myers Squibb Co. Earnings Analysis: By the Numbers Jul 29 2015
Under the radar names you're missing Jul 28 2015
NantKwest Surges As Biggest Biotech Market Cap IPO Jul 28 2015
Wait, Will Allergan Really Buy Biogen or Amgen? Jul 28 2015
Celgene Corporation Commences Tender Offer for Receptos, Inc. Jul 28 2015
Celgene Corporation Commences Tender Offer for Receptos, Inc. Jul 28 2015
CELGENE CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 28 2015
Gilead Earnings Preview and The Moment of Truth Jul 27 2015
Morgan Stanley Raises Price Target On Celgene, Still Highlights Several Risks Jul 27 2015
Biogen: Buy the Stock Get the Pipeline for Free Jul 27 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK